The U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer’s disease in nearly two decades, in a controversial decision that left the agency defending its reputation and its science. Aduhelm (aducanumab) treats Alzheimer’s by clearing out amyloid beta, a sticky protein known to form plaques in the brains of early-stage… read on > read on >
Although the number of teens who use e-cigarettes has dropped significantly, new research suggests that vaping rates are still too high. “This study underscores that flavored e-cigarettes, especially JUUL, have caused the epidemic of youth e-cigarette use and nicotine addiction in the U.S. and shows why the [U.S. Food and Drug Administration] and other policymakers… read on > read on >
That third or fourth cup of coffee may do more than make your heart race: New research suggests it could significantly increase your risk of glaucoma if you’re genetically predisposed to the eye disease. The study included more than 120,000 British people, aged 39 to 73, who provided information about their caffeine consumption and their… read on > read on >
Women whose diets tend to feed inflammation may have a heightened risk of breast cancer, a preliminary study suggests. The study, of more than 350,000 women, found that the more “pro-inflammatory” foods women consumed, the higher their breast cancer risk. The term refers to foods thought to contribute to chronic low-grade inflammation throughout the body… read on > read on >
The portion of food that you put on your plate and how fast you eat it could determine how much you’re eating — or potentially overeating. A new study found that when people were given larger portions of macaroni and cheese for lunch, they ate more, as much as 43% more when the portion size… read on > read on >
The first new Alzheimer’s drug in nearly two decades was approved by the U.S. Food and Drug Administration on Monday, despite opposition from the agency’s own independent advisory committee and some experts who said there wasn’t enough proof the drug could actually help patients. In clinical trials, aducanumab (Aduhelm) showed a 22% reduction in the… read on > read on >
Bots, not individual users, drive much of the COVID-19 misinformation on Facebook, according to a new study. Bots are large numbers of automated accounts controlled by single users. “The coronavirus pandemic has sparked what the World Health Organization has called an ‘infodemic’ of misinformation,” said study leader John Ayers, a scientist who specializes in public… read on > read on >
MONDAY, June 7, 2021 (American Heart Association News) — Nice weather and a receding pandemic should make for a joyous, memorable summer, especially after a year of lockdowns, frustration and discouraging news. For kids, and their parents, it’s also a chance to get back on the road to normal after a long COVID-19 detour. “I’m… read on > read on >
Plunging vaccination rates are imperiling President Joe Biden’s goal of getting COVID shots into the arms of at least 70% of American adults by July 4, while public health experts worry that Southern states, where immunization numbers are the lowest, could see a spike in cases over the summer. The United States is averaging fewer… read on > read on >
After being diagnosed with bladder cancer, some patients face an almost impossible decision — have their bladder removed or take a risk knowing that the cancer may be more likely to spread if the bladder is left intact. But what if there was another way? For David Cabelis, 68, the decision was more straightforward than… read on > read on >
